Rex Bright was named president and chief executive officer ofArcturus Pharmaceutical Corp of Woburn, Mass. He wasmarketing director of the dermatological division of Johnson &Johnson's Ortho Pharmaceutical Corp.
Medicis Pharmaceutical Corp. of New York named Harold E.Chappelear president and chief executive officer. He wascorporate executive vice president of the Upjohn Co.
Applied Bioscience International Inc. of Foster City, Calif.,named Swep T. Davis to its board of directors and made himpresident of its Environmental Sciences Group. Davis waspresident and chief executive of Concord Resources Group Inc.,a hazardous waste management company. Applied Bio alsonamed Cornelius C. Smith Jr. a pricipal. He was vice president ofcommunity and employee health, safety and environment atUnion Carbide Corp.
MGI Pharma Inc. of Minneapolis appointed Hugh E. Miller to itsboard of directors. Miller is a member of the board of directorsand executive committees for the Wilmington Trust Co. and forthe Medical Center of Delaware.
Immunogen Inc. of Cambridge, Mass., named Dixie Esseltinedirector of oncology. She was associate director of clinicalresearch and development at Ortho-McNeil, a subsidiary ofJohnson & Johnson.
Embrex Inc. of Research Triangle Park, N.C., named C. CrawfordCarter director of sales. Carter had responsibility for domesticsales and the marketing of products for the poultry industryfor BASF Corp.
Martyn D. Greenacre, formerly chairman Europe for SmithKlineBeecham Pharmaceuticals, was named to the board of directorsof Cephalon Inc. of West Chester, Pa.
(c) 1997 American Health Consultants. All rights reserved.